Item 4.01 Changes in Registrant's Certifying Accountant.
(b) New Independent Registered Public Accounting Firm
On June 13, 2022, the board of directors of Statera Biopharma, Inc. (the
"Company") approved the engagement of BF Borgers CPA, PC ("BF Borgers") as the
Company's independent registered public accounting firm effective as of June 13,
2022. During the Company's two most recent fiscal years ended December 31,
2021 and 2020 and from January 1, 2022 through June 13, 2022, neither the
Company nor anyone on its behalf consulted BF Borgers regarding either (i) the
application of accounting principles to a specified transaction, either
completed or proposed, or the type of audit opinion that might be rendered on
the Company's consolidated financial statements, and no written report or oral
advice was provided to the Company that BF Borgers concluded was an important
factor considered by the Company in reaching a decision as to the accounting,
auditing or financial reporting issue; or (ii) any matter that was the subject
of a disagreement or reportable event as defined in Regulation S-K, Item
304(a)(1)(iv) and Item 304(a)(1)(v) except as follows:
The Company consulted with BF Borgers regarding the matters raised by the
Company's former auditor Turner, Stone & Company, LLP's ("Turner Stone") in its
April 11, 2022 letter to the Company wherein Turner Stone indicated its
determination to resign as the Company's auditor (the "Resignation Letter").
BF Borgers consulted with Turner Stone regarding the matters raised in the
Resignation Letter and is of the view that the circumstances giving rise to
Turner Stone's resignation can be adequately addressed by the Company.
The Company has provided a copy of this Current Report on Form 8-K to BF
Borgers, as successor to Turner Stone, and asked that BF Borgers furnish the
Company with a letter addressed to the Securities and Exchange Commission
stating whether it agrees with the statements made by the Company in response to
Item 304(a)(2)(ii)(D) of Regulation S-K.
Item 7.01 Regulation FD Disclosure.
On June 14, 2022, the Company issued a press release regarding its appointment
of BF Borgers. The press release is attached hereto as Exhibit 99.1 and
incorporated herein by this reference.
The information contained in the press release attached hereto is being
furnished and shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise
subject to the liability of that Section, and shall not be incorporated by
reference into any registration statement or other document filed under the
Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) The following exhibits are filed with this Current Report:
Exhibit No. Description
99.1 Press Release dated June 14, 2022 (furnished herewith).
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses